Blind mole rats Spalax (BMR) are small subterranean rodents common in the Middle East. BMR is distinguished by its adaptations to life underground, remarkable longevity (with a maximum documented lifespan of 21 y), and resistance to cancer. Spontaneous tumors have never been observed in spalacids. To understand the mechanisms responsible for this resistance, we examined the growth of BMR fibroblasts in vitro of the species Spalax judaei and Spalax golani. BMR cells proliferated actively for 7-20 population doublings, after which the cells began secreting IFN-β, and the cultures underwent massive necrotic cell death within 3 d. The necrotic cell death phenomenon was independent of culture conditions or telomere shortening. Interestingly, this cell behavior was distinct from that observed in another long-lived and cancer-resistant African mole rat, Heterocephalus glaber, the naked mole rat in which cells display hypersensitivity to contact inhibition. Sequestration of p53 and Rb proteins using SV40 large T antigen completely rescued necrotic cell death. Our results suggest that cancer resistance of BMR is conferred by massive necrotic response to overproliferation mediated by p53 and Rb pathways, and triggered by the release of IFN-β. Thus, we have identified a unique mechanism that contributes to cancer resistance of this subterranean mammal extremely adapted to life underground. BMRs are very long-lived for their size. The maximum lifespan documented for the animals kept in our animal facility is 21 y (3). In comparison, mice and rats belonging to the same superfamily have a maximum lifespan of 4 y (4, 5). Furthermore, BMRs show a striking resistance to cancer. Our observation of thousands of captive animals did not show a single case of spontaneous tumor development over a 40-y period. Cancer accounts for ∼23% of human mortality (6). In mice and rats, cancer mortality is very high, reaching 90% in some strains (7,8).Animals have evolved multiple mechanisms to protect themselves from cancer. These mechanisms include cell-cycle checkpoints, DNA repair, programmed cell death, and replicative senescence controlled by a network of tumor-suppressor genes, such as p53 and Rb. Anticancer adaptations differ between species, which may explain the differences in cancer susceptibility (9-11). Mice have been used extensively as models for cancer research. However, mice are more prone to cancer and are likely to possess fewer anticancer defenses, thus limiting a potential for discovery of novel anticancer pathways. Hence, there is great value in studying anticancer mechanisms in cancer-resistant species. Subterranean mammals are good candidates for these studies.We showed previously that the BMR p53 gene contains an arginine to lysine substitution at a site corresponding to human p53 position 174, where mutations are often found in human tumors (12). The R174K substitution affects the DNA-binding domain of p53; the resulting protein is capable of inducing cellcycle arrest but is defective in initiating apoptosis. We hypothes...